Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Aktis Oncology, Inc. (AKTS) had Non-Operating Income/Expense of $4.75M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$3.38M |
|
$-24.14M |
|
-- |
|
$3.38M |
|
$32.28M |
|
$-28.90M |
|
|
Non-Operating Income/Expense |
$4.75M |
$-24.14M |
|
$-24.14M |
|
$-24.14M |
|
$-24.14M |
|
$-24.14M |
|
$-24.14M |
|
$-28.90M |
|
$-29.05M |
|
55.30M |
|
55.30M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$524.54M |
|
$15.97M |
|
$33.06M |
|
$557.60M |
|
$32.13M |
|
-- |
|
$40.63M |
|
$72.76M |
|
$484.84M |
|
$484.84M |
|
$484.84M |
|
55.32M |
|
| Cash Flow Statement Financials | |
$-44.83M |
|
$-248.17M |
|
$337.70M |
|
$38.93M |
|
$83.64M |
|
$44.71M |
|
$6.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-853.99% |
|
-853.99% |
|
-- |
|
-713.48% |
|
-713.48% |
|
$-47.95M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-4.98% |
|
-4.98% |
|
-4.33% |
|
-4.98% |
|
$8.76 |
|
$-0.87 |
|
$-0.81 |
|